Walleye Trading
KIN

Walleye Trading’s Kindred Biosciences, Inc. KIN Stock Holding History

Walleye Trading’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-800
Closed -$3K – 5634
2016
Q2 		$3K Sell
800
-100
-11% -$368 ﹤0.01% 5088
2016
Q1 		$3K Sell
900
-6,800
-88% -$24K ﹤0.01% 5075
2015
Q4 		$26K Buy
7,700
+6,100
+381% +$28.3K ﹤0.01% 4288
2015
Q3 		$8K Buy
1,600
+1,000
+167% +$6.17K ﹤0.01% 4478
2015
Q2 		$4K Buy
+600
New +$4.26K ﹤0.01% 4572

Other funds holding KIN

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Trading's KIN Position: Q3 2016 in Review

Walleye Trading sold out of Kindred Biosciences, Inc. (KIN) in Q3 2016, closing a stake of 800 shares — an estimated $3K sold.

Walleye Trading first reported a position in KIN in Q2 2015 and held it in 5 quarters. The position peaked at $26K in Q4 2015. 41 funds tracked by Wall St. Rank hold KIN as of Q3 2016.

  • Walleye Trading reported no remaining Kindred Biosciences, Inc. position as of Q3 2016 after selling out during the quarter.
  • Walleye Trading sold 800 Kindred Biosciences, Inc. shares in Q3 2016, an estimated $3K.
  • Walleye Trading first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 5 quarters.
  • Walleye Trading's Kindred Biosciences, Inc. position peaked at $26K in Q4 2015.
  • 41 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2016.

Based on Walleye Trading's 13F filing for Q3 2016, filed 14 Nov 2016.